ArticleAnalytical cellular pathology (Amsterdam)2022

Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer.

Xinhang Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.